State lawmakers are back in session and considering a variety of drug pricing legislation. If you and your family rely on generic and biosimilar prescription drugs to manage your health, then demand that your state lawmakers reject any legislation that puts your FDA-approved, affordable medicines at risk.

The Medicaid Generics Penalty ignores the fundamental difference between how brand-name drugs and generics are priced. Unless it is repealed, it could destabilize a largely healthy market and impede access to lifesaving drugs. Let's not jeopardize their access to safe, effective medicine.

Generic and biosimilar prescription medicines keep us healthy and wealthy. Because competition from FDA-approved generics keeps prices down, more than 9 out of 10 generic drug prescriptions are filled for just $20 or less. However, experts warn that these savings are in jeopardy. Subscribe now to receive alerts on pivotal legislation and opportunities where you can advocate for affordability.